Response and relapse outcomes in trials assessing CD19 CAR-T therapy with 4-1BB/CD3ζ co-stimulatory domains in B-cell acute lymphoblastic leukemia with potential bridging to allogeneic hematopoietic cell transplantation. The gene discussed is CD19; the disease is B-cell acute lymphoblastic leukemia.